Health & Wellness
While the classic symptoms of Parkinson's disease include tremors and slow movements, Parkinson's can also affect someone's memory, including "working memory." Working memory is defined as the ability to temporarily store and manipulate information, rather than simply repeat it. The use of working memory is important in planning, problem solving and independent living.
The findings underline the importance of addressing sleep disorders in the care of patients with Parkinson's, and indicate that working memory capacity in patients with Parkinson's potentially can be improved with training. The results also have implications for the biology of sleep and memory.
The results were published this week in the journal Brain.
"It was known already that sleep is beneficial for memory, but here, we've been able to analyze what aspects of sleep are required for the improvements in working memory performance," says postdoctoral fellow Michael Scullin, who is the first author of the paper. The senior author is Donald Bliwise, professor of neurology at Emory University School of Medicine.
The study, which is the first to investigate this and to compare it with people whose spouse died or survived from something other than a heart attack, also found that men were more susceptible to depression and suicide after their wife's survival or death from an acute myocardial infarction (AMI), than women.
Using Danish registries, including the National Civil Status Registry that shows whether people are married or not, researchers in the USA and Denmark compared 16,506 spouses of people who died from an AMI between 1997 and 2008 with 49,518 spouses of people who died from causes unrelated to AMI. They also matched 44,566 spouses of patients who suffered a non-fatal AMI with 131,563 spouses of people admitted to hospital for a non-fatal condition unrelated to AMI. They looked at the use of antidepressants and benzodiazepines (used for treating anxiety) before and up to a year after the event, records of contact with the health system for depression, and suicide.
The patients' immune systems become damaged, leaving them unable to fend off germs as healthy people do. What triggers this isn't known, but the disease does not seem to be contagious.
This is another kind of acquired immune deficiency that is not inherited and occurs in adults, but doesn't spread the way AIDS does through a virus, said Dr. Sarah Browne, a scientist at the National Institute of Allergy and Infectious Diseases.
She helped lead the study with researchers in Thailand and Taiwan where most of the cases have been found since 2004. Their report is in Thursday's New England Journal of Medicine.
"This is absolutely fascinating. I've seen probably at least three patients in the last 10 years or so" who might have had this, said Dr. Dennis Maki, an infectious disease specialist at the University of Wisconsin in Madison.
It's still possible that an infection of some sort could trigger the disease, even though the disease itself doesn't seem to spread person-to-person, he said.
The disease develops around age 50 on average but does not run in families, which makes it unlikely that a single gene is responsible, Browne said. Some patients have died of overwhelming infections, including some Asians now living in the U.S., although Browne could not estimate how many.
The extract, known as epigallocatechin gallate, has been known to have preventative anti-cancer properties but fails to reach tumours when delivered by conventional intravenous administration.
However, in initial laboratory tests at the Universities of Strathclyde and Glasgow, researchers used an approach which allowed the treatment to be delivered specifically to the tumours after intravenous administration. Nearly two-thirds of the tumours it was delivered to either shrank or disappeared within one month and the treatment displayed no side effects to normal tissues.
The tests are thought to be the first time that this type of treatment has made cancerous tumours shrink or vanish.
In the tests, on two different types of skin cancer, 40% of both types of tumour vanished, while 30% of one and 20% of another shrank. A further 10% of one of the types were stabilised.
Duchenne muscular dystrophy occurs in about 1 out of every 3,600 male infants and "worsens quickly," according to the U.S. National Library of Medicine. It is caused by a defective gene for a protein (dystrophin) in the muscles and there is no known cure.
The unique interdisciplinary study identifies new potential therapeutic targets for intervening in this devastating disease, says Christopher Ward, PhD, associate professor at the UM School of Nursing and senior author of the study.
"We show that an enhancement in the microtubule network structure, a stiffening, underlies dysfunction in Duchenne muscular dystrophy," says Ward.
"The brain can be loaded with all sorts of problems," said André Fenton of New York University. "What this work shows is that experience can overcome those disabilities."
Fenton's team made the discovery completely by accident. His team was interested in what Fenton considers a core problem in schizophrenia: the inability to sift through confusing or conflicting information and focus on what's relevant.
"As you walk through the world, you might be focused on a phone conversation, but there are also kids in the park and cars and other distractions," he explained. "These information streams are all competing for our brain to process them. That's a really challenging situation for someone with schizophrenia."
Forty percent of Danish men are moderately overweight. For thirteen weeks, a research team at the Faculty of Health and Medical Sciences followed 60 heavy -- but healthy -- Danish men in their efforts to get into better shape. Half of the men were set to exercise for an hour a day, wearing a heart-rate monitor and calorie counter, while the second group only had to sweat for 30 minutes. Research results show that 30 minutes of exercise hard enough to produce a sweat is enough to turn the tide on an unhealthy body mass index:
"On average, the men who exercised 30 minutes a day lost 3.6 kilo in three months, while those who exercised for a whole hour only lost 2.7 kg. The reduction in body mass was about 4 kg for both groups," reports Mads Rosenkilde, PhD student, Department of Biomedical Sciences.
Yu-Ting Mao, a former graduate student under Sarah L. Pallas, professor of neuroscience, explored how the brain's ability to change, or neuroplasticity, affected the brain's ability to process sounds when both visual and auditory information is sent to the auditory thalamus.
The study was published in the Journal of Neuroscience.
The auditory thalamus is the region of the brain responsible for carrying sound information to the auditory cortex, where sound is processed in detail.
When a person or animal loses input from one of the senses, such as hearing, the region of the brain that processes that information does not become inactive, but instead gets rewired with input from other sensory systems.
In the case of this study, early brain injury resulted in visual inputs into the auditory thalamus, which altered how the auditory cortex processes sounds.
The current issue of the journal Pediatric and Developmental Pathology includes a study of the role of the protein -catenin in pediatric aggressive fibromatosis. Researchers analyzed the expression and mutation status of -catenin in this tumor.
Although it is rare, with only two to four cases per million people, aggressive fibromatosis shows infiltrative growth. The tumor is benign, but it can harm other structures within the body and cause organ dysfunction, so it is often removed. However, pediatric aggressive fibromatosis has a recurrence rate of 75 percent, higher than that of adults.
Through immunohistochemistry, the current study analyzed biopsy samples from 32 patients, 21 of whom were experiencing recurrent cases of the tumor. All patients were between the ages of 3 and 15. The study found that abnormal expression of -catenin appears to be frequent in pediatric aggressive fibromatosis.
By altering the fine balance of gut bacteria which influence our metabolism, even small amounts of the drugs entering the food chain could have caused obesity rates to rise, researchers claim.
Although the use of antibiotics on farms is now banned in the EU due to the risk of germs becoming drug-resistant, it was commonplace in the 1950s and is still permitted in the US.
Prof Martin Blaser of New York University, who led the study, said: "The rise of obesity around the world is coincident with widespread antibiotic use, and our studies provide an experimental linkage.
"It is possible that early exposure to antibiotics primes children for obesity later in life."






